Previous studies have convincingly argued that reactive oxygen species (ROS) contribute to the development of several major types of sensorineural hearing loss, such as noise-induced hearing loss (NIHL), drug-induced hearing loss, and age-related hearing loss. However, the underlying molecular mechanisms induced by ROS in these pathologies remain unclear. To resolve this issue, we established an in vivo model of ROS overproduction by generating a transgenic (TG) mouse line expressing the human NADPH oxidase 4 (NOX4, NOX4-TG mice), which is a constitutively active ROSproducing enzyme that does not require stimulation or an activator. Overproduction of ROS was detected at the cochlea of the inner ear in NOX4-TG mice, but they showed normal hearing function under baseline conditions. However, they demonstrated hearing function vulnerability, especially at high-frequency sounds, upon exposure to intense noise, which was accompanied by loss of cochlear outer hair cells (OHCs). The vulnerability to loss of hearing function and OHCs was rescued by treatment with the antioxidant Tempol. Additionally, we found increased protein levels of the heatshock protein 47 (HSP47) in models using HEK293 cells, including H 2 O 2 treatment and cells with stable and transient expression of NOX4. Furthermore, the up-regulated levels of Hsp47 were observed in both the cochlea and heart of NOX4-TG mice. Thus, antioxidant therapy is a promising approach for the treatment of NIHL. Hsp47 may be an endogenous antioxidant factor, compensating for the chronic ROS overexposure in vivo, and counteracting ROS-related hearing loss.
Reactive oxygen species (ROS), including superoxide anions, hydroxyl radicals, hydrogen peroxide (H 2 O 2 ), and singlet oxygen, are known to play key roles in numerous physiological and pathological processes (Leto et al. 2009 ). Although appropriate levels of ROS are indispensable for cell survival and differentiation (Leto et al. 2009 ), high levels induce oxidative stress in several organs, including the inner ear, heart, brain, liver, and kidney, thereby triggering pathologies, such as sensorineural hearing loss (SNHL), myocardial infarction, heart failure, neurodegenerative disorders, and liver and renal fibrosis (Altenhofer et al. 2012; Wong and Ryan 2015; Yang et al. 2015a; Ma et al. 2017) .
Hearing loss is one of the most common sensory deficits in humans, and about 90% of the cases are accounted for by SNHL (Li et al. 2017) . Most SNHL is caused by loss of hearing sensitivity as a result of damage and/or cell death in the cochlea, an auditory detection organ (Wong and Ryan 2015) . The cochlea contains two types of hair cells (HCs) , that is, inner HCs (IHCs) and outer HCs (OHCs). IHCs are responsible for detecting sounds and transmitting the acoustic information to the brain. In contrast, OHCs are responsible for an active mechanical amplification process that leads to high sensitivity and fine frequency resolution. The cochlea has a tonotopic gradient along the length of the lumen in which the basal turn detects high-frequency sounds, while the apical turn detects low-frequency sounds (Goutman et al. 2015; Wong and Ryan 2015) .
Previous studies have convincingly argued that ROS contribute to the development of several major types of SNHL, such as noise-induced hearing loss (NIHL); druginduced hearing loss, including the one caused by cisplatin; and age-related hearing loss (Wong and Ryan 2015; Yang et al. 2015a) . Among these pathologies, the ototoxic effect of oxidative stress has been most frequently studied in NIHL. For example, biomarkers of lipid peroxidation, such as 4-hydroxynonenal (4-HNE) and malondialdehyde, are reportedly increased in the cochlear sensory epithelium after noise exposure (NE) (Le Prell et al. 2007; Fetoni et al. 2013; Choi and Choi 2015) . In addition, antioxidants such as N-acetyl-Lcysteine (Coleman et al. 2007; Le Prell et al. 2007; Choi et al. 2008 ) and 4-hydroxy-2,2,6,6-tetramethylpiperidine-noxyl (Tempol) (Murashita et al. 2006; Minami et al. 2007) have been reported to have a therapeutic effect on NIHL. Peri-traumatic application of these drugs can decrease the permanent hearing threshold shift induced by NE. Moreover, supplementation of antioxidants in animals and humans has been reported to prevent progression of age-related hearing loss in some studies (Tavanai and Mohammadkhani 2017) .
NADPH oxidase 3 (Nox3), one of the main NOXs in the inner ear, has been found to be increased in the cochlea after administration of cisplatin in rats, which leads to ROS overproduction and induces apoptosis in the cochlea, including OHC (Mukherjea et al. 2008; Kaur et al. 2016 ). Subsequently, a small interfering RNA (siRNA) for Nox3 was reportedly effective in reducing OHC damage and hearing function in rats (Mukherjea et al. 2010) . On the contrary, Nox3 was proposed to be protective against NE based on a genome-wide association study, in which Nox3 knockout (KO) mice were shown to be susceptible to NIHL (Lavinsky et al. 2015) . In addition, increased expression of Nox4 and Nox1 as well as Nox3 after administration of cisplatin was reported in the mouse cochlea (Kim et al. 2010) . Thus, ROS function and its underlying molecular mechanism inducing SNHL may be different depending on the injury applied and the Nox isoform involved.
To advance the understanding of the underlying molecular mechanisms in ROS-induced SNHL, and especially in NIHL, we established an in vivo model for ROS overproduction by generating a transgenic (TG) mouse line expressing human NOX4, which is a constitutively active ROS-producing enzyme (Leto et al. 2009 ).
Materials and methods

Plasmids
The human NOX4 in pcDNA3.1 was a kind gift from Dr. Thomas L. Leto (Boudreau et al. 2014) . NOX4 with HindIII/NotI sites at the 5 0 and 3 0 ends was amplified by PCR, cloned into the HindIII/NotI site of the p3xFLAG-CMV-10 vector (Sigma-Aldrich, St Louis, MO, USA), and named 3xFLAG-NOX4. NOX4(1-305) in pcDNA3.1 was generated by insertion of a stop codon immediately after Ser 305 of NOX4 using the QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies, Santa Clara, CA, USA). In NOX4(1-305), the C-terminal, FAD-, and NADPH-binding domains have been deleted, leading to loss of the ROS-generating capability (Boudreau et al. 2014) .
Generation of transgenic mice
This study was approved by the Institutional Animal Care and Use Committee and carried out according to the Kobe University Animal Experimentation Regulation (24-04-08 and 26-03-05) . This study was not pre-registered. Two PCR products, 3xFLAG-NOX4, with an XhoI site at the 5 0 end, and the polyadenylation (polyA) signal of the rabbit b-globin, with an StuI site at the 3 0 end, were amplified by PCR and cloned into the XhoI/StuI sites of the pCAGGS vector, containing the CAG promoter, using the In-Fusion HD TM cloning kit (Takara Bio Inc., Tokyo, Japan). The final construct is shown in Fig. 1a .
After confirming the identity of the plasmid by sequencing and the protein expression of 3xFLAG-NOX4 in HEK293 cells by immunoblotting, its capabilities for ROS production were examined. ROS production was found to be comparable between 3xFLAG-NOX4 and untagged NOX4 (Fig. 1b) . Thereafter, a purified fragment digested with SalI and StuI, which contained the CAG promoter, 3xFLAG-NOX4, and polyA, was injected into fertilized eggs obtained at the pronuclear stage from C57BL/6 mice (UNITECH, Kashiwa, Japan). Founder (F0) and first generation (F1) mice were screened by PCR using the following primer pair: 5 0 -CCTACAGCTCCTGGGCAACGTGTGCTGGT-3 0 (located in the CAG promoter) and 5 0 -AGAGGGAAAAAGATCTCAGTGGTAT-3 0 (located in the polyA). We obtained four F0 and two F1 mouse lines. The copy number of the transgene (CAG promoter; 3xFLAG-NOX4; polyA), as integrated into the genome, was evaluated by Southern blotting; one line carried 12 and the other carried 17 copies. The second and later generations of heterozygous NOX4-TG mice were used for subsequent analyses. Offspring were genotyped by PCR using the above-mentioned primer pair. All mice were identified by numbered ear tags. Mice were housed in specific pathogen-free conditions using the individually ventilated cage system (Techniplast, Tokyo, Japan), and allowed food and water ad libitum. The animal facility was maintained on a 14 h light and 10 h dark cycle at 23 AE 2°C and 50 AE 10% humidity. Mice from control group were always treated and assessed first, followed by experimental group. No randomization was performed. Females were used in the analyses unless otherwise indicated (mice younger than 1 week were not The cassette contains the CAG promoter, the 3xFLAG-tagged NOX4, and the rabbit b-globin poly A sequence. (b) ROS production, measured using a luminol-based chemiluminescence (CL) method, in HEK293 cells transfected with mock, NOX4, 3xFLAG-tagged NOX4, or NOX4(1-305) plasmids. No significant difference is detected between NOX4 and 3xFLAG-tagged NOX4 (n = 4; p = 0.2841; Student's t-test). (c) Immunoblotting analysis using anti-FLAG and anti-actin-b (used as loading control) antibodies. Expression of FLAGtagged NOX4 protein is confirmed in the cochlea and heart of NOX4-TG mice at P7 (right panels) but not in control mice (left panels). Multiple bands marked by arrowheads, probably correspond to glycosylated forms of NOX4 (predicted MW = 66.5 kDa). FLAG-NOX4 levels are much higher in the heart, even with much lower protein loaded, as evident by actin-b bands. n = 4. (d) ROS production assessment in cochlear lysates obtained from P7 mice, using a luminol-based CL method. Overproduction of ROS in the cochleae of NOX4-TG mice is suppressed to control levels by Tempol or DPI; n = 4; p = 0.016 [control vs. TG], p = 0.010 [TG vs. TG+Tempol] , and p = 0.013 [TG vs. TG+DPI] ). *p < 0.05; one-way ANOVA with Bonferroni's post hoc test. (e) Representative sections of cochleae from P14 control and NOX4-TG mice stained with anti-4-HNE antibody. Rectangles in the upper panels (scale bars, 50 lm) indicate the magnified areas shown in the lower panels (scale bars, 25 lm). The asterisk and black dot indicate Corti's tunnel and Nuel's space, respectively. Graph on the right shows the quantification of 4-HNE immunoreactivity in outer hair cells (OHCs; p = 0.045), spiral ligament (SL; p = 0.001), and stria vascularis (SV; p = 0.045). n = 5; *p < 0.05; **p < 0.001; Student's t-test. differentiated based on sex). Age-matched wild type (WT) siblings were used as control.
Antibodies and chemicals
The following specific antibodies (Abs) were used (monoclonal unless indicated): 4-HNE (HNE-J2; JaICA, Fukuroi, Japan; 1 : 100), heat-shock protein 47 (HSP47) Cell culture and transfection HEK293 cells (ATCC, Cat# CRL-1573, RRID:CVCL_0045) were maintained in Eagle's minimal essential medium (Wako Pure Chemical Industries, Osaka, Japan) containing 10% fetal bovine serum (Nichirei Biosciences, Tokyo, Japan), 100 lM nonessential amino acids (Wako), 100 units/mL penicillin, and 100 lg/mL streptomycin at 37°C in 5% CO 2 . Stable protein-expressing HEK FLAG-NOX4 and HEK cont cells were generated by transfection of the 3xFLAG-NOX4 or the control p3xFLAG-CMV-10 plasmids, respectively, by electroporation (NEPA21; NEPA GENE, Ichikawa, Japan), followed by selection with the antibiotic G418 (0.5 mg/mL; Wako). For transfection, HEK293 cells were seeded into six-well dishes at 2.5 9 10 5 cells/well, 48 h before. Plasmids were transfected into HEK293 cells using FuGENE6 (Promega, Madison, WI, USA). Six hours after transfection, the cell culture medium was replaced with complete medium.
Sample preparation and immunoblotting
The membranous cochleae (two from each mouse) of postnatal day 7 (P7) or P4À6 pups, and the heart of adult NOX4-TG and control mice were homogenized and lysed in lysis buffer (Nakamura et al. 2017) with 0.1% Triton X and protease inhibitor cocktail (Nacalai Tesque). Forty-eight hours after transfection with plasmids or 24 h after treatment with H 2 O 2 , HEK293 cells were lysed in the same lysis buffer as above. Each lysate was centrifuged at 13 000 g for 10 min at 4°C and supernatants were measured with the bicinchoninic acid protein assay kit (Thermo Fisher Scientific, Waltham, MA, USA). The supernatants were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred onto polyvinylidene difluoride membranes. The membranes were incubated overnight at 4°C with the anti-FLAG, anti-HSP47, or anti-p22 phox Ab, and then incubated for 30 min at 23°C with a HRPconjugated secondary Ab. Immunoreactivity was detected using the enhanced chemiluminescence (ECL) detection system (Bio-Rad Laboratories, Hercules, CA, USA). For quantitative assessment of immunoreactive bands, ImageJ software (National Institutes of Health) was used as previously described (Ueyama et al. 2016) . Protein expression levels were normalized to those of tubulina, actin-b, or GAPDH.
ROS production assay
Twenty-four hours after transfection, 2 9 10 5 HEK293 cells in
Hank's balanced salt solution (HBSS; Wako) were used for assays. For detection of overall ROS, we performed a chemiluminescence (CL) assay. Cells were incubated in the presence of 200 lM luminol and 10 units/mL HRP (Sigma-Aldrich) for 10 min, and CL signal was detected using a luminometer (Mithras LB940; Berthold Detection Systems, GmbH), as previously described (Ueyama et al. 2015) .
To measure ROS production in the cochleae of NOX4-TG mice, two membranous cochleae were dissected from each NOX4-TG or control mouse at P7. Tissues of the organ of Corti (OC) and the lateral wall of the cochlea, including the spiral ligament (SL) and stria vascularis (SV), were collected in HBSS. After homogenization, lysates were centrifuged at 20 000 g for 15 min at 4°C and precipitates containing NOX4 were resuspended in HBSS. After measuring the protein concentration of the membrane pellets using the bicinchoninic acid protein assay kit, equal amounts of protein were used for CL detection of ROS using the luminometer, and incubated for 10 min in the presence of 10 lM FAD, 500 lM NADPH, 1 mM NaN 2 , 200 lM luminol, and 10 units/mL of HRP, as previously described (Ago et al. 2004; Ueyama et al. 2015) . ROS production was inhibited by a 10-min prior incubation with 0.1 lM Tempol or 5 lM DPI. Because this ROS assay was performed in vitro (cell-free), Tempol was used at the minimum concentration as previously reported (Bhattacharyya et al. 2008) .
Immunohistochemistry
To examine surface preparations of the cochleae, dissected tissues were fixed with 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB, pH 7.4) and decalcified in 0.12 M EDTA for 1 week at 4°C (Ueyama et al. 2014) . After permeabilization with phosphatebuffered saline (PBS) containing 0.3% Triton X-100, fixed tissues were incubated with Alexa Fluor 488-conjugated phalloidin for 2 h at 23°C. Stained tissues were mounted in Prolong anti-fade (Invitrogen) with a coverslip and observed under an LSM700 confocal microscope (Carl Zeiss, Jena, Germany). To evaluate OHC loss after NE, the percentages of remaining OHCs were calculated separately at the apical, middle, and basal turns of the cochlea.
To analyze cross-sections of cochleae, tissues were isolated from P14 or adult mice and fixed with 4% PFA in 0.1 M PB. Decalcified cochleae were embedded into paraffin blocks and cut into 6-lm slices on a Leica RM2125 RTS manual rotary microtome (Leica Biosystems, Wetzlar, Germany). Sections were immunostained after deparaffinization through a xylene and ethanol graded series. For antigen unmasking, the slides were bathed in HistoVT One (Nacalai Tesque) for 20 min at 80°C. Retrieved tissues were blocked in either 10% normal goat serum and 3% H 2 O 2 (Nacalai Tesque) in PBS/ 0.03% Triton, or in 0.1% phenylhydrazine (Nacalai Tesque) in PBS/ 0.03% Triton for 20 min at 23°C. The tissues were incubated with primary Abs for 2 h at 23°C in PBS/0.03% Triton, followed by MACH 2 Universal HRP-Polymer Detection (BIOCARE Medical, Pacheco, CA, USA) for 30 min at 23°C, as previously described (Nakamura et al. 2017) .
To analyze cryosections of hearts, adult mice were transcardially perfused with ice-cold 0.9% saline solution, and subsequently with 4% PFA in 0.1 M PB. Hearts were dissected and post-fixed overnight in the same fresh fixative. Twenty-micrometer cryosections were immunostained for HSP47, followed by MACH 2 Universal HRP-Polymer Detection. Sections were visualized after staining with 3,3-diaminobenzidine tetrahydrochloride (DAB, Sigma-Aldrich) and 0.02% H 2 O 2 in Tris-buffered saline, pH 7.6. Slides were washed in PBS/0.03% Triton and mounted in Entellan New (Merck Millipore, Billerica, MA, USA), coverslipped, and photographed under a light microscope (Axioplan II; Carl Zeiss) equipped with a DP26 camera (Olympus, Tokyo, Japan).
For the quantitative assessment of DAB intensity (evaluated using 4-HNE or Hsp47 Ab), we used ImageJ software and the color deconvolution plugin for proper separation of the DAB color spectra, as previously described (Varghese et al. 2014) . Briefly, the region of interest was manually determined with the polygon or freehand tool, and then the deconvoluted image was analyzed pixelby-pixel. The color threshold for the positive area was defined in the range of 61-125/255, and the ratio of the positive to the total image area was calculated and presented as a percentage of the control sample ratio.
Auditory brainstem response measurement and NE For auditory brainstem response (ABR) measurements (Ueyama et al. 2016) , mice were anesthetized with chloral hydrate (500 mg/ kg, i.p.) and stainless steel needle electrodes were placed at the vertex and ventro-lateral to the left and right ears. Electroencephalographic recording was performed with BioSigRP Software and the TDT System 3 (Tucker-Davis Technologies, Alachua, FL, USA), in order to generate a click or tone-burst stimulation at 4, 12, or 20 kHz (click, 4, 12, and 20 kHz for mice under baseline conditions; 4, 12, and 20 kHz for mice in the NE experiment). ABR waveforms were recorded for 12.8 ms at a sampling rate of 40 000 Hz with 505 000 Hz bandpass-filter settings. Waveforms from 500 stimuli were averaged. ABR threshold was determined by decreasing the sound intensity by 5-dB steps from 90 dB sound pressure level (SPL) and defined as the lowest stimulus intensity that produced a reliable wave III on the ABR. When there was no response to the stimulation at 90 dB, the threshold was considered as 100 dB. Blinded data analysis was performed by two otologists or two scientists. ABR of control and NOX4-TG mice under baseline conditions was measured at the age of 3, 5 (14.3-15.7 g), 7 and 24 (27.0-30.0 g) weeks (Fig. 3d) . The experiments were terminated if the mice showed signs of unbearable pain.
For NE experiments (Fig. 3d) , 5-week-old control and NOX4-TG mice were anesthetized with chloral hydrate and exposed to 110 dB SPL of octave-band noise, centered at 8 kHz, for 1 h inside a sound chamber. These conditions of noise exposure were shown to cause a permanent threshold shift in WT mice (Yamaguchi et al. 2017) .
Each animal was placed in a cage and the cage placed in the sound chamber, which was fitted with a speaker (300 HT; FOSTEX, Akishima, Japan) driven by a noise generator (SF-06; RION, Kokubunji, Japan) and power amplifier (DAD-M100proHT; FLY-ING MOLE, Hamamatsu, Japan). To ensure the uniformity of the stimulus, we calibrated and measured the sound levels with a soundlevel meter (NL-26; RION), positioned at the level of the animal's head. The ABRs were measured immediately before NE. Then, ABR was sequentially measured immediately after NE (day 0), and on days 1, 2, 5, 7, and 14 after NE. Hearing deterioration because of NE was evaluated by measuring the ABR threshold shift, calculated by the differences in ABR threshold before and after the NE test. In the antioxidant rescue experiment, Tempol was injected intraperitoneally twice, immediately before and 24 h after NE, at a concentration of 300 mg/kg, determined based on previous studies (Lahiani et al. 2016) . During the experiments, the mice were observed through a small window in the sound chamber, and the experiments were terminated if the mice showed signs of unbearable pain.
Immunoprecipitation and mass spectrometry HEK cont and HEK FLAG-NOX4 cells were homogenized in ice-cold buffer (20 mM Tris-HCl, pH 7.4, 120 mM NaCl, 1 mM EDTA, 5 mM EGTA, and 0.3% 3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate) containing protease and phosphatase inhibitor cocktails. Lysates were immunoprecipitated with anti-FLAG Ab-conjugated magnetic beads. The immunoprecipitates were washed three times with the homogenization buffer, separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and then analyzed by silver staining (Silver Stain MS Kit; Wako) or immunoblotting. Subsequently, analysis of protein sequences by mass spectrometry was carried out as described previously (Oshiro et al. 2007) . Briefly, the silver-stained gel regions that seemed to be different between the HEK cont and HEK FLAG-NOX4 samples were broadly excised and de-stained. The proteins in the gels were reduced and alkylated, followed by in-gel digestion with trypsin in 25 mM ammonium bicarbonate for 15 h at 37°C. The resulting peptides were then subjected to liquid chromatography electrospray ionization mass spectrometry/mass spectrometry (MS/MS) using the LCQ Advantage ion-trap mass spectrometer (Thermo Finnigan, Somerset, NJ, USA). Protein identification, based on product ion mass lists, was performed by MASCOT 'MS/MS ion search'.
Statistical analysis
The exact number of experiments for each condition is provided in the figure legends. All data are presented as the mean AE SEM. Two groups were compared using an unpaired, two-tailed Student's t-test. For comparisons of more than two groups, one-way or two-way ANOVA was performed, followed by Bonferroni's post hoc test for pairwise group differences. Statistical analyses were performed using Prism 6.0 software (GraphPad, San Diego, CA, USA). Sample size calculation was not performed.
Results
Generation of NOX4-TG mice Low levels of Nox4 and Nox1 are detected in the mouse cochlea and these levels are increased after administration of cisplatin in the mouse cochlea (Kim et al. 2010) . NOX3 is one of the main NOX isoforms in the inner ear; however, it is a multicomponent enzyme that requires at least four other components (p22 phox , Noxo1 or p47 phox , Noxa1 or p67 phox , Rac) in order to work functionally in mouse cells (Ueyama et al. 2006; Leto et al. 2009 ). In addition, the effects of NOX3 after injury are still controversial. For example, Nox3 is ototoxic after administration of cisplatin (Mukherjea et al. 2008; Kaur et al. 2016) , whereas it is protective after NE (Lavinsky et al. 2015) . However, NOX4 heterodimer with p22 phox is the only constitutively active enzyme in the sevenmembered NOX family, which produces ROS without the need for a co-activator or stimulation (Leto et al. 2009 ). Therefore, to establish a mouse model with overproduction of ROS in the cochlea, we decided to generate NOX4-TG mice. The expression levels of endogenous p22
phox protein are up-regulated by introduction of exogenous NOX4 (Leto et al. 2009 ); hence we reconstituted NOX4-based ROS production by a single transfection of NOX4-expressing plasmid, without p22 phox . Using a luminol-based method and HEK293 cells expressing various NOX4 expression or mock plasmids, we confirmed that untagged and 3xFLAG-tagged NOX4 at the N-terminus (3xFLAG-NOX4) showed comparable ROS-producing capabilities (Fig. 1b) , consistent with a previous report (Martyn et al. 2006) . In NOX4-TG mice, the expression of 3xFLAG-NOX4 was systemically controlled by the CAG promoter (Fig. 1a) . Hence, we confirmed the capability for ROS production of two F1 NOX4-TG mouse lines obtained, using primary fibroblasts and astrocytes (data not shown). ROS production was higher in cells from mice carrying 17 copies of the transgene than from mice carrying 12 copies, and thus further studies were performed using the mouse line carrying 17 copies. NOX4-TG mice were fertile and did not show any gross body abnormalities.
Overproduction of ROS in the inner ear of NOX4-TG mice
Immunoblotting analysis using an anti-FLAG Ab showed that FLAG-tagged NOX4 protein was expressed in the cochlea and heart of NOX4-TG but not of control mice at P7 (Fig. 1c) . We then examined the in vivo function of FLAG-NOX4 in the cochlea of NOX4-TG mice at P7. A ROS production assay using membranous cochleae showed that ROS production was higher in NOX4-TG than in control mice (Fig. 1d) . As expected, the generation of ROS in NOX4-TG cochleae was suppressed to control levels after incubation with the antioxidant Tempol (Wilcox and Pearlman 2008) or the NOX inhibitor DPI (Fig. 1d) . Furthermore, although the morphology of the OC at the basal turn of the cochlea in NOX4-TG mice showed no apparent abnormality, 4-HNE immunoreactivity, a marker for lipid peroxidation (Zarkovic et al. 2017) , was higher in the SL, SV, and OHCs of the cochlea in NOX4-TG than in control mice (Fig. 1e) . Taken together, these results (ROS overproduction and lipid peroxidation in the cochlea) indicate that NOX4-TG mice can be used as a model for ROS overproduction in the cochlea.
Normal hearing function and cochlear morphology in NOX4-TG mice
We evaluated the hearing function of 3-, 5-, 7-, and 24-weekold NOX4-TG mice, bred under normal noise conditions, by measuring the ABR to click and tone-burst stimuli, the latter at frequencies of 4, 12, and 20 kHz (Fig. 3d) . Unexpectedly, we did not find any significant difference in the ABR between NOX4-TG and control mice regardless of stimulus or age, indicating that there is no direct effect of ROS overproduction on hearing function in mice bred under normal noise conditions. ABR data at 5 and 24 weeks are shown in Fig. 2a . No apparent morphological differences were observed in the basal, middle, and apical turns of the cochleae between 5-week-old NOX4-TG and control mice, with few HC loss detected in the entire area that was examined (Fig. 2b) .
Hearing vulnerability of NOX4-TG mice after NE Next, we examined whether ROS overproduction in NOX4-TG mice affects their hearing function after stress and accelerates the progress of NIHL. We exposed anesthetized, 5-week-old NOX4-TG and control mice to intense noise with an intensity of 110 dB SPL for 1 h (Fig. 3d) , which is known to induce a permanent threshold shift in the hearing level of WT mice (Yamaguchi et al. 2017) . ABR threshold shifts (in dB SPL) were highest immediately after NE at day 0 and gradually decreased in the 14-day period after the injury, being more remarkable when tested at higher (12 and 20 kHz) than at low frequencies (4 kHz) (Fig. 3a) . At day 0, the ABR threshold shifts of NOX4-TG mice were comparable to those of control mice (Fig. 3a) . However, at day 5, the threshold shifts at high frequencies (12 and 20 kHz), but not at 4 kHz, became significantly higher in NOX4-TG mice (49.0 AE 1.9 and 61.0 AE 3.3, for 12 and 20 kHz, respectively) than in control mice (34.0 AE 3.4 and 44.0 AE 3.3, for 12 and 20 kHz, respectively; Fig. 3a) . At 20 kHz at days 7 and 14, the ABR threshold shifts were significantly higher in NOX4-TG mice (59.0 AE 2.4 at day 7 and 53.0 AE 5.1 at day 14) than in control mice (36.9 AE 3.8 at day 7 and 32.1 AE 5.3 at day 14) (Fig. 3a) .
We also examined the morphology of the apical, middle, and basal turns of the cochlea at day 14. A few OHCs were missing in the middle and basal turns, but not in the apical turn, in control mice, consistent with a permanent ABR threshold shift at high frequencies (Fig. 3b) . The remaining OHCs were significantly less at the basal turn of the cochlea in NOX4-TG mice (71.4 AE 5.4% in NOX4-TG mice and 93.3 AE 0.6% in control mice; Fig. 3b and c) , in line with the significantly increased ABR threshold, observed specifically at 20 kHz. We did not observe a loss of IHCs in either NOX4-TG or control mice (Fig. 3c) , consistent with previous studies reporting that OHCs are mainly damaged in NIHL (Harding et al. 2005; Yang et al. 2015b; Yamaguchi et al. 2017) . These results suggest that the greater OHC loss is one of the main causes of the increased threshold shift in NOX4-TG mice in the NE experiment.
Rescue of hearing vulnerability in NOX4-TG mice by the antioxidant Tempol
To confirm that the exacerbated NIHL in NOX4-TG mice was caused by ROS, we applied the antioxidant Tempol (300 mg/kg) twice intraperitoneally; immediately before and 24 h after NE (Fig. 3d) . Tempol functions by metabolizing superoxide to H 2 O 2 (termed as superoxide dismutasemimetic action) and by catalytically and stoichiometrically metabolizing H 2 O 2 (catalase-like action) (Wilcox and Pearlman 2008) . As expected, the NIHL observed in the NOX4-TG group was rescued by treatment with Tempol. At day 1, the ABR threshold shifts were significantly lower in the Tempol-treated NOX4-TG (NOX4-TG + Tempol; 48.3 AE 3.3 at 12 kHz and 53.3 AE 3.3 at 20 kHz) than in the untreated control group (66.6 AE 1.7 at 12 kHz and 65.0 AE 2.9 at 20 kHz). At day 14, the ABR threshold shifts in the NOX4-TG + Tempol group (15.0 AE 2.9 at 4 kHz, 25.0 AE 2.9 at 12 kHz, and 38.3 AE 3.3 at 20 kHz) were decreased to the levels observed in WT control mice (Figs 4a, see 3a) . Thus, the threshold shifts at high frequencies (12 and 20 kHz), but not at 4 kHz, were significantly lower in the group treated with Tempol than in the untreated group during the entire 14-day period (Fig. 4a) . Loss of OHCs at day 14 was also decreased in the NOX4-TG + Tempol group compared with the untreated control NOX4-TG group, most apparently in the basal turn of the cochlea (Fig. 4b) . The percentage of remaining OHCs in the basal cochlear turn was significantly larger in the NOX4-TG + Tempol group (95.3 AE 1.8%) than in the control NOX4-TG group (78.3 AE 5.5%; Fig. 4b,  right) . These results strongly suggest that the exacerbated NIHL observed in NOX4-TG mice is because of the increased levels of ROS.
Increased HSP47 protein levels due to ROS Although our results suggested the involvement of ROS in NIHL progression in NOX4-TG mice, their hearing function was maintained under baseline conditions, suggesting chronic activation of signaling pathways that protect against oxidative stress. To explore these putative pathways, we attempted to identify proteins that bind to and function with NOX4, by means of immunoprecipitation assays. We used lysates of HEK293 cells that were stably transfected with 3xFLAG-NOX4 (HEK ) or 3xFLAG (HEK cont ) and incubated them with magnetic bead-conjugated anti-FLAG monoclonal Ab. Immunoblotting analysis confirmed the expression of 3xFLAG-NOX4 protein, as well as increased levels of the endogenous NOX4-heterodimerizing p22 phox protein, in HEK FLAG-NOX4 but not in HEK cont cells (Fig. 5a ). Using mass spectrometry, we then identified six proteins that potentially form a complex with NOX4; heat-shock protein (a) Five-week-old mice were exposed to intense noise (110 dB) for 1 h. Auditory brainstem response (ABR) threshold shifts (dB SPL) between pre-and post-NE, were tested at 4, 12, and 20 kHz and monitored immediately after NE (day 0) and for the next 14 days. A significant difference was observed at 12 kHz at day 5 (*p = 0.041) and at 20 kHz at days 5, 7, and 14 (*p = 0.033, 0.022, and 0.028, respectively). n = 7 in control and n = 5 in NOX4-TG mice; two-way ANOVA with Bonferroni's post hoc test. (b) Representative histochemical images showing HCs at the three cochlear turns (apical, middle, and basal) of the organ of Corti, in sections obtained from control and NOX4-TG mice at day 14 and stained using Alexa Fluor 488-labeled phalloidin. OHC loss is most prominent in the basal turn, which is responsive to high-frequency tones, and is more severe in NOX4-TG than in control mice. White dots indicate missing OHCs. The quantification of the percentage of OHCs remaining in the apical, middle, and basal turn is shown in c (n = 7 in control mice and 8 in NOX4-TG mice; **p = 0.002 in the basal turn; Student's t-test). Scale bars, 25 lm. (d) Chart showing the timings of ABR measurements under baseline conditions and in NE experiments. Bf, immediately before NE; Af, immediately after NE. regulated protein 78, apoptosis-inducing factor, nucleolin, and lipoprotein lipase. Among these, we focused on HSP47, a collagen-specific molecular chaperone that has been reportedly involved in cell survival (Kawasaki et al. 2015; Franco et al. 2016) . Therefore, we investigated whether HSP47 can form a complex with NOX4, using immunoprecipitation. Unexpectedly, we failed to detect HSP47 in immunoprecipitates of HEK FLAG-NOX4 lysates, indicating that HSP47 does not bind to NOX4 (Fig. 5b) . Instead, immunoblotting using whole cell lysates showed significantly increased HSP47 protein levels in HEK cells than in HEK cont cells (Fig. 5b) . Increased HSP47 protein levels were also confirmed in cells transfected with untagged NOX4 or 3xFLAG-NOX4, but not in those transfected with mock plasmid or NOX4(1-305) (Fig. 5c) . Furthermore, HSP47 protein levels in HEK293 cells increased after treatment with H 2 O 2 in a dose-dependent manner; this increase was statistically significant after treatment with 100 (p = 0.011) but not 10 (p = 0.680) lM H 2 O 2 (Fig. 5d) . These results suggest that ROS produced by NOX4 increase HSP47 protein levels.
Increased Hsp47 protein levels in the cochlea of NOX4-TG mice Finally, we examined Hsp47 protein levels in the cochlea of NOX4-TG mice. In the cochlea of adult control mice, we detected Hsp47 immunoreactivity in OHCs, the SL, spiral limbus (LB), and spiral ganglion (SG); the SV was weakly positive. The immunoreactivity of Hsp47 at these regions was significantly more intense in NOX4-TG than in agematched control mice (Fig. 6a) . To confirm the increased protein levels of Hsp47 in the cochlea of NOX4-TG mice, we performed immunoblotting. Indeed, Hsp47 protein levels were significantly increased in NOX4-TG above those in control mice, as early as by the first postnatal week (Fig. 6b) . In addition, we found that immunoreactivity of Hsp47 in the heart was also significantly stronger in adult NOX4-TG mice Fig. 4 Tempol reduces the NE-induced hearing vulnerability and OHC loss in NOX4-TG mice. (a) Intense noise (110 dB) was applied to 5-week-old NOX4-TG mice for 1 h, with or without combined pre-and post-treatment with Tempol (300 mg/kg, i.p.). Auditory brainstem response (ABR) threshold shifts at 4, 12, and 20 kHz were monitored immediately after NE (day 0) and for the next 14 days. At 12 kHz, p = 0.029 at day 1, 0.025 at day 2, 0.021 at day 5, 0.016 at day 7, and 0.014 at day 14. At 20 kHz, p = 0.026 at day 1, 0.010 at day 2, 0.026 at day 5, 0.005 at day 7, and 0.004 at day 14. n = 3; *, p < 0.05; **, p < 0.01; two-way ANOVA with Bonferroni's post hoc test. (b) Representative sections stained using Alexa Fluor 488-labeled phalloidin, showing OHCs at the basal turn of the organ of Corti at day 14 (left). White dots indicate missing OHCs. Graph on the right shows the percentage of OHCs remaining in the basal turn (n = 6 in control and 5 in NOX4-TG mice; *p = 0.031; Student's t-test). Scale bars, 25 lm.
than in age-matched control mice (Fig. 6c) . This result was also confirmed by immunoblotting analysis of Hsp47 levels in the heart (Fig. 6d) . These results suggest that the NOX4-ROS-Hsp47 pathway is present and functions in many different tissues, organs, and cells. In contrast, we could not detect any Hsp47 protein up-regulation in the cochlea 2 days after NE by immunohistochemistry in either WT or NOX4-TG mice at 2 weeks of age (data not shown).
Discussion
Establishment of a transgenic ROS overproduction mouse model Gene-targeted mouse models are useful tools for studying the mechanism of ROS involvement in various types of organ failure, including SNHL. Several mouse models with genetic modifications of ROS metabolism have been reported to show increased cochlear damage. For example, mice with deletion of superoxide dismutase 1 (Sod1), a major antioxidant molecule, show increased vulnerability to age-related hearing loss (McFadden et al. 1999) . Several KO mouse lines with deficiencies in other major antioxidants or their regulators, such as Sod2 (Tuerdi et al. 2017) , glutathione peroxidase 1 (Ohlemiller et al. 2000) , and nuclear factor erythroid-2 related factor 2 (Nrf2) (Honkura et al. 2016) , show vulnerability to NIHL. Moreover, pejvakin KO mice, which have disturbed peroxisome antioxidant activity, show a similar phenotype (Delmaghani et al. 2015) . Unlike these strains, this newly established NOX4-TG mouse line is a genetic model of increased ROS production and is thus more and NOX4-TG mice at P4-P6, using an anti-HSP47 antibody. Tubulin was used as a loading control. Graph shows the quantification of the immunoreactive bands (n = 3; *p = 0.015; Student's t-test). (c) Representative sections of the heart from adult control and NOX4-TG mice, immunostained with an anti-HSP47 antibody. Graph shows the quantification of Hsp47 immunoreactivity (n = 4; **p = 0.003; Student's t-test). Scale bars, 200 lm. (d) Immunoblotting analysis of heart lysates obtained from adult control and NOX4-TG mice, using anti-HSP47 and anti-GAPDH antibodies, the latter used as a loading control. Graph shows the quantification of Hsp47 protein levels (n = 3; *p = 0.017; Student's t-test).
suitable for studying the direct effects of ROS exposure on various organs. The auditory phenotype that we observed in NOX4-TG mice is the accelerated NIHL, which is limited to high-frequency sounds. This is consistent with the results from previous defense-failure models, indicating that a common pathology is induced in the cochlea, either by failure of defense against or overload of ROS. NOX4 is a constitutively active NOX, localized at internal cell membranes, and mainly produces H 2 O 2 (H 2 O 2 and superoxide are approximately 90% and 10%, respectively) (Leto et al. 2009; Takac et al. 2011; Nisimoto et al. 2014) . In contrast, NOX members, other than Nox4 and Duox-s, primarily produce superoxide and probably have a different subcellular localization (Leto et al. 2009; Nisimoto et al. 2014; Ueyama et al. 2015) . Hence, although superoxide is spontaneously converted to H 2 O 2 (Winterbourn 2017) , the different effects of ROS in NIHL observed in Nox3 KO mice (Lavinsky et al. 2015) and our NOX4-TG mice could be explained by the different effect of H 2 O 2 , produced by NOX4, and of superoxide, produced by NOX3.
Hearing phenotype in NOX4-TG mice under baseline conditions and after NE Infusion of chemicals, which are known to generate H 2 O 2 , superoxide, or hydroxyl radicals, into the perilymphatic space, cause a significant increase in the threshold of compound action potentials of the cochlear nerve (Clerici and Yang 1996) . Paraquat, for example, enhances superoxide production in a reaction catalyzed by NADPH oxidase. When delivered into the perilymph through the round window, paraquat induces hearing loss and HC loss (Bielefeld et al. 2005) . Moreover, H 2 O 2 treatment of cultured OCs isolated from P3 WT mice causes HC death in a concentration-dependent manner (Baker and Staecker 2012) . NOX4-TG mice; however, have no baseline cochlear damage. One possible explanation for this is the insufficient ROS overproduction. An early study reported that NE causes a permanent hearing threshold shift by producing fourfold higher ROS levels in the cochlea (Ohlemiller et al. 1999) . However, a more recent report suggested that even lower levels of ROS can cause irreversible damage to the cochlea. Furthermore, cisplatin treatment, which increases ROS production by 1.8-2.2 folds, decreases cell viability in HEI-OC1 cells, an auditory cell line (Kim et al. 2010; Chang et al. 2014) . In cultured OCs, cisplatin treatment causes a 1.19-fold higher ROS production, leading to increased loss of HCs (Kikkawa et al. 2014) . Moreover, a 2.05-fold increase in ROS induced by NE was reported to cause permanent hearing loss, as confirmed by ABR in vivo (Wilson et al. 2014) . These data suggest that the 1.7-fold higher levels of ROS seen in NOX4-TG mice should be sufficient to affect baseline hearing function.
Another plausible explanation of this contradiction is that chronic exposure to excessive ROS in a genetically engineered model, such as NOX4-TG mice, may result in a reduced effect on cochlear function as compared to acute exposure. Indeed, NOX4-TG mice show a hearing vulnerability upon NE that is induced by ROS, as confirmed by the compensation observed after the antioxidant treatment. Mouse models with antioxidant-defense failure reportedly have normal hearing (Honkura et al. 2016; Tuerdi et al. 2017) or only subtle hearing loss (Ohlemiller et al. 2000; Delmaghani et al. 2015) under baseline conditions, but show exacerbated NIHL and OHC loss after NE. For example, mice lacking Nrf2, which is a transcription factor regulating the major antioxidant response elements (Loboda et al. 2016) , have normal hearing but increased susceptibility to NE (Honkura et al. 2016) . Interestingly, the expression of Nrf2-targeted genes is not altered in Nrf2 KO mice, suggesting the presence of other antioxidant signaling molecules and pathways activated in the chronic phase of ROS/antioxidant imbalance. Considering the above, the hypothetical modified redox signaling(s), probably mediated by antioxidants and induced by chronic ROS exposure, is insufficient to prevent the irreversible damage caused by an acute increase in ROS.
With respect to the lesions, we found that OHC is mainly affected by the acutely increased ROS levels; however, other regions, including the SL, SV, LB, and SG could also be involved in the pathology of NOX4-TG mice. The SL and SV were also reported to be affected by NE (Sha and Schacht 2017) , and our 4-HNE immunostaining showed increased ROS production in these structures. Indeed, although we detected a larger threshold shift in NOX4-TG mice at 12 kHz, particularly at day 5, we observed a significantly higher OHC loss specifically in the basal turn of the cochlea 14 days after NE.
Potential role of HSP47 in hearing protection
In this study, we identified Hsp47 as a novel signaling molecule that is up-regulated in the cochlea upon NOX4-induced ROS stress. Hsp47 is a collagen-specific molecular chaperone and plays an important role in the biosynthesis, structural assembly, and homeostasis of collagen (Nagata et al. 1988; Ito and Nagata 2017) . It was reported to have cytoprotective effects against oxidative stress, since it could inhibit the H 2 O 2 -induced apoptosis in the lymphoma U937 cell line, when added to the cells (Franco et al. 2016) . Previous studies have shown that NOX4 is involved in the development of fibrosis in several organs, including lung (Hecker et al. 2009 ), kidney (Barnes and Gorin 2011) , and liver (Jiang et al. 2012) . Knockdown of Hsp47 by siRNA was shown to decrease Nox4 levels both in vitro and in vivo in fibrosis models (Morry et al. 2015) . These findings support our hypothesis that both NOX4 and Hsp47 are involved in a common signaling pathway, while, our data further demonstrate the opposite regulation of Hsp47 by NOX4 and suggest that NOX4ÀROSÀHsp47 signaling is regulated in an interdependent manner. Altogether, these data indicate that Hsp47 is an attractive candidate as a hearing-protective molecule against chronic ROS overexposure. In contrast, Hsp47 protein levels were not increased in the cochlea after NE, suggesting that up-regulation of Hsp47 in vivo is not induced in the acute phase after ROS exposure, consistent with a previous report (Gong et al. 2012) . It is thus possible that sufficient amounts of Hsp47, administered in the acute phase, may contribute to reducing cochlear damage. Further studies are required to explore the functional mechanism and potential therapeutic effect of HSP47 on NIHL.
In summary, NOX4-TG mice have normal hearing, but show hearing vulnerability after intense NE, suggesting that antioxidant pathways are induced/activated in chronic ROS overexposure. These results also suggest that ROS have different effects on functional and damaged tissue, depending on chronic or acute exposure. Hsp47 protein levels are upregulated in the cochlea of NOX4-TG mice, suggesting that HSP47 may be an endogenous antioxidant factor compensating for chronic ROS overexposure.
